Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication

Journal of Innate Immunity

Volumn 6, Issue 2, 2014, Pages 182-191

  Pei, Rongjuan ^a,b   Qin, Bo ^a,b   Zhang, Xiaoyong ^a   Zhu, Wandi ^b   Kemper, Thekla ^a   Ma, Zhiyong ^a   Trippler, Martin ^a   Schlaak, Joerg ^a   Chen, Xinwen ^b   Lu, Mengji ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

HBV; IFIT1; IFIT2

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; SMALL INTERFERING RNA; TETRATRICOPEPTIDE REPEAT 1 PROTEIN; TETRATRICOPEPTIDE REPEAT 2 PROTEIN; TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; CARRIER PROTEIN; IFIT1 PROTEIN, HUMAN; IFIT2 PROTEIN, HUMAN; PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STIMULATION; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SOUTHERN BLOTTING; TRANSIENT TRANSFECTION; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING; DRUG EFFECTS; GENETICS; HEPG2 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LIVER CELL CARCINOMA; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; VIROLOGY;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HEP G2 CELLS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; PROMOTER REGIONS, GENETIC; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS REPLICATION;

EID: 84896402213     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000353220     Document Type: Article

References (38)

1. Seeger C, Mason WS: Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68. (Pubitemid 30143840)
2. McMahon BJ: Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25(suppl 1):3-8. (Pubitemid 41254588)
3. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV: Cytotoxic t lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 1994; 91: 3764-3768. (Pubitemid 24139512)
4. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV: Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 25-36. (Pubitemid 26054933)
5. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV: Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825-829. (Pubitemid 29291352)
6. Wieland S, Thimme R, Purcell RH, Chisari FV: Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004; 101: 6669-6674. (Pubitemid 38586032)
7. Wieland SF, Chisari FV: Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005; 79: 9369-9380. (Pubitemid 41022281)
8. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N, Lascar RM, Brown D, Gilson RJ, Tedder RJ, Dusheiko GM, Jacobs M, Klenerman P, Maini MK: Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137: 1289-1300.
9. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MB, Chisari FV: Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci USA 1996; 93: 4589-4594. (Pubitemid 26162806)
10. Wieland SF, Guidotti LG, Chisari FV: Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 2000; 74: 4165-4173. (Pubitemid 30214422)
11. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV: Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci USA 2005; 102: 9913-9917. (Pubitemid 40993667)
12. Xu C, Guo H, Pan XB, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo JT: Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 2010; 84: 9332-9340.
13. Anderson AL, Banks KE, Pontoglio M, Yaniv M, McLachlan A: Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1?-null HBV transgenic mice. J Virol 2005; 79: 11045-11052. (Pubitemid 41170645)
14. Wieland SF, Vega RG, Muller R, Evans CF, Hilbush B, Guidotti LG, Sutcliffe JG, Schultz PG, Chisari FV: Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 2003; 77: 1227-1236. (Pubitemid 36055546)
15. Nguyen DH, Hu J: Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J Virol 2008; 82: 6852-6861. (Pubitemid 351977706)
16. Baumert TF, Rosler C, Malim MH, von Weizsacker F: Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 2007; 46: 682-689. (Pubitemid 47436113)
17. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP: Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102: 8321-8326. (Pubitemid 40800087)
18. Gordien E, Rosmorduc O, Peltekian C, Garreau F, Brechot C, Kremsdorf D: Inhibition of hepatitis B virus replication by the interferoninducible MxA protein. J Virol 2001; 75: 2684-2691. (Pubitemid 32185032)
19. Peltekian C, Gordien E, Garreau F, Meas-Yedid V, Soussan P, Willams V, Chaix ML, Olivo- Marin JC, Brechot C, Kremsdorf D: Human MxA protein participates to the interferon- related inhibition of hepatitis B virus replication in female transgenic mice. J Hepatol 2005; 43: 965-972. (Pubitemid 41627981)
20. Li N, Zhang L, Chen L, Feng W, Xu Y, Chen F, Liu X, Chen Z, Liu W: MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen. Hepatology 2012; 56: 803-811.
21. Gao B, Duan Z, Xu W, Xiong S: Tripartite motif- containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located ring domain. Hepatology 2009; 50: 424-433.
22. Mao R, Zhang J, Jiang D, Cai D, Levy JM, Cuconati A, Block TM, Guo JT, Guo H: Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 2011; 85: 1048-1057.
23. Wacher C, Muller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, Terenzi F, Sen GC, King NJ, Campbell IL: Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol 2007; 81: 860-871. (Pubitemid 46067911)
24. Terenzi F, Hui DJ, Merrick WC, Sen GC: Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 2006; 281: 34064-34071. (Pubitemid 46036616)
25. Guo J, Hui DJ, Merrick WC, Sen GC: A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 2000; 19: 6891-6899. (Pubitemid 32011682)
26. Hui DJ, Bhasker CR, Merrick WC, Sen GC: Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.METtRNAi. J Biol Chem 2003; 278: 39477-39482. (Pubitemid 37248504)
27. Li HT, Su YP, Cheng TM, Xu JM, Liao J, Chen JC, Ji CY, Ai GP, Wang JP: The interaction between interferon-induced protein with tetratricopeptide repeats-1 and eukaryotic elongation factor-1A. Mol Cell Biochem 2010; 337: 101-110.
28. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR, Burckstummer T, Stefanovic A, Krieger S, Bennett KL, Rulicke T, Weber F, Colinge J, Muller M, Superti- Furga G: IFIT1 is an antiviral protein that recognizes 5 ? -triphosphate RNA. Nat Immunol 2011; 12: 624-630.
29. Wang C, Pflugheber J, Sumpter R Jr, Sodora DL, Hui D, Sen GC, Gale M Jr: Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J Virol 2003; 77: 3898-3912. (Pubitemid 36350931)
30. Terenzi F, Saikia P, Sen GC: Interferon-inducible protein, p56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J 2008; 27: 3311-3321.
31. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M Jr, Shi PY, Diamond MS: 2 ? -O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 2010; 468: 452-456.
32. Zhang X, Ma Z, Liu H, Liu J, Meng Z, Broering R, Yang D, Schlaak JF, Roggendorf M, Lu M: Role of Toll-like receptor 2 in the immune response against hepadnaviral infection. J Hepatol 2012; 57: 522-528.
33. Qiu J, Qin B, Rayner S, Wu CC, Pei RJ, Xu S, Wang Y, Chen XW: Novel evidence suggests hepatitis B virus surface proteins participate in regulation of HBV genome replication. Virol Sin 2011; 26: 131-138.
34. Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M: Modulation of hepatitis B virus replication and hepatocyte differentiation by microRNA-1. Hepatology 2011; 53: 1476-1485.
35. Mao R, Zhang J, Jiang D, Cai D, Levy JM, Cuconati A, Block TM, Guo JT, Guo H: Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol 2012; 85: 1048-1057.
36. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, Williams BR, Chisari FV: Interferon- regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 2002; 76: 2617-2621. (Pubitemid 34184846)
37. Hosel M, Quasdorff M, Wiegmann K, Webb D, Zedler U, Broxtermann M, Tedjokusumo R, Esser K, Arzberger S, Kirschning CJ, Langenkamp A, Falk C, Buning H, Rose-John S, Protzer U: Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009; 50: 1773-1782.
38. Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F: Control of hepatitis B virus replication by innate response of Hepa- RG cells. Hepatology 2010; 51: 63-72.